Cargando…
Medical Compliance of Fibrate and the Decreased Risk of Age-Related Macular Degeneration in Dyslipidemia-Related Diseases: A Population-Based Cohort Study
The purpose of the current study is to evaluate the incidence of age-related macular degeneration (AMD) in dyslipidemia-related diseases with or without the use of fibrate. Patients were defined as dyslipidemia-related diseases according to the diagnostic code and lab exam arrangement, then the popu...
Autores principales: | Wang, Kai, Hsieh, Ming-Ju, Chien, Hsiang-Wen, Lee, Chia-Yi, Yeh, Chao-Bin, Huang, Jing-Yang, Yang, Shun-Fa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796116/ https://www.ncbi.nlm.nih.gov/pubmed/33401577 http://dx.doi.org/10.3390/ijerph18010301 |
Ejemplares similares
-
Systemic Dyslipidemia in Age-related Macular Degeneration: An Updated Systematic Review and Meta-analysis
por: Li, Brandon, et al.
Publicado: (2023) -
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010) -
Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022) -
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
por: Alagona, Peter
Publicado: (2010) -
Increased incidence of age-related macular degeneration in sensorineural hearing loss: A population-based cohort study
por: Lee, Chia-Yi, et al.
Publicado: (2019)